|
Current therapy of myelodysplastic syndromes.
|
Jul 2013
|
Blood Rev
|
myelodysplastic syndromes (MDS)
|
|
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes
|
May 2023
|
Current Treatment Options in Oncology
|
myelodysplastic syndromes (MDS)
|
|
Current State of the Art: Management of Higher Risk Myelodysplastic Syndromes
|
Aug 2016
|
Clin Lymphoma Myeloma Leuk.
|
myelodysplastic syndromes (MDS)
|
|
Current state of prognostication and risk stratification in myelodysplastic syndromes
|
Mar 2015
|
Curr Opin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Current outcome of HLA identical sibling vs. unrelated donor transplants in severe aplastic anemia: an EBMT analysis
|
Jan 2015
|
Haematologica
|
aplastic anemia
|
|
Current concepts in the pathophysiology and treatment of aplastic anemia
|
Dec 2013
|
Hematology Am Soc Hematol Educ Program
|
aplastic anemia
|
|
Current and novel therapeutic approaches in myelodysplastic syndromes
|
Jul 2014
|
J Community Support Oncol
|
myelodysplastic syndromes (MDS)
|
|
Current and emerging strategies for management of myelodysplastic syndromes
|
Dec 2020
|
Blood reviews
|
myelodysplastic syndromes (MDS)
|
|
CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).
|
Jun 2015
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses
|
Oct 2012
|
Can Oncol Nurs J
|
myelodysplastic syndromes (MDS)
|
